BIOLIFE SOLUTIONS INC — Director's Dealing 2022

Feb 18, 2022

SEC Form 4/A — Form 4/A

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-11-30

Reporting Person: Wichterman Troy (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	Common Stock	S	33	$37.59	Disposed	22432	Direct

Footnotes

F1: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

F2: On December 2, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares.